C 6 H 9 F 3 N 2 , monoclinic, P21/n (no. 14), a = 10.6224(9) Å, b = 11.8639(9) Å, c = 13.3139(11) Å,
Source of material
Stoichiometric amount of 2-methylpropane-1,2-diamine (1.68 g, 19.06 mmol) was dissolved in 50 mL of dioxone in one neck round bottom flask equipped with a reflux condenser and magnetic stirring bar. Ethyl 2,2,2-trifluoroacetate (2.71 mL, 3.97 g, 38.12 mmol) was added dropwise and the mixture was stirred at moderate heating (50°C) overnight. The solvent was completely removed and viscous colorless product was obtained. The product was further purified by distillation under reduced pressure (0.1 mm Hg, RT), (Yield 79%). M.P. 55−57°C.
Experimental details
Hydrogen atoms were placed at the calculated positions and included using a riding model with U iso (H) = 1.2Ueq or 1.5Ueq of the adjacent non-hydrogen atom.
Comment
The development of imidazole-based molecules has speedily increased recently, since it can be used extensively in medicinal chemistry as man-made drugs, agrochemicals, artificial acceptors, biomimetic catalysts, supramolecular material [4] [5] [6] . Several imidazole medicinal drugs have been used for treatment of broad types of diseases, imidazole derivatives demonstrated anti-inflammatory, analgesic, antiviral, antitubercular, antimicrobial, antimalarial, anti-diabetic and anticancer activity [7] [8] [9] [10] . The molecule C 6 H 9 F 3 N 2 crystallizes in the space group P21/n. The asymmetric unit of the title structure contains two independent molecules (figure), with a high similarity in their structural parameters like bond lengths and angles. The similarity of these two structures extends to their hydrogenbonding motifs. The molecules in the title structure are connected via intermolecular hydrogen bonds, of N-H· · · N type (N2· · · N4: 2.91 Å; N1· · · N3′: 2.93 Å; ′ = 0.5 + x, 0.5 − y, −0.5 + z).
